恶性肠梗阻的治疗进展  

Advances in the treatment of malignant intestinal obstruction

作　　者：许鹤洋[1] 褚忠华[1] 

机构地区：[1]中山大学孙逸仙纪念医院胃肠外科,广州510120

出　　处：《岭南现代临床外科》2012年第6期469-472,共4页Lingnan Modern Clinics in Surgery

基　　金：广东省自然科学基金(10151008901000071)

摘　　要：恶性肠梗阻是指由恶性肿瘤引起的肠梗阻,通常是结直肠癌以及妇科恶性肿瘤晚期并发症。患者预后较差,平均生存期只有4～9个月。目前治疗恶性肠梗阻包括手术、置入可扩式支架、药物治疗,以及经皮内镜下胃造口和鼻胃管引流。除此之外,由于患者一般体质较差,还可给予肠外营养支持,不过该治疗效果存在争议。本文就目前恶性肠梗阻的多种治疗方案进行综合分析,并作一定的评估。Malignant bowel obstruction(MBO) is a complication caused by colorectal and gynecological malignancies,which can cause intestinal obstruction.Patients usually have a poor prognosis and their mean survival time is between 4-9 months.The current treatments include surgery,self-expanding stents,pharmacotherapy,percutaneous endoscopic gastrostomy and nasogastric tube.Besides,taking into account of the patients ' poor physical condition,parenteral alimentation can be used,however,there is still disputation on its efficacy.This passage will mainly focus on the current methods of MBO and make some analytic evaluation.

关 键 词：恶性肿瘤 肠梗阻 治疗 

分 类 号：R574.2[医药卫生—消化系统]